Literature DB >> 24381741

Do we protect or discriminate? Representation of senior adults in clinical trials.

Joanna Kaźmierska1.   

Abstract

AIM: The analysis of barriers responsible for low recruitment of older patients in clinical trials and presentation of possible solutions are the subject of this review.
BACKGROUND: Europe's population is ageing, and the group of people who more frequently develop neoplasms increases. Oncologists are confronted with a new challenge - how to treat cancer in this group of patients, especially considering the lack of Evidence Based Medicine (EBM) guidelines for treatment of cancer in the elderly population.
MATERIALS AND METHODS: Medline search and analysis of studies published between 1999 and 2012, containing key words: senior adults, cancer, elderly in clinical trials.
RESULTS: Detailed analysis of relevant studies demonstrated that senior adults are underrepresented in clinical trials. Moreover, there is a lack of trials exclusively designed for this heterogeneous group of patients. The analysis of reasons for low recruitment of older patients in clinical trials revealed barriers dependent on patient's and physician's attitudes as well as institutional and logistic problems.
CONCLUSIONS: It is necessary to widen the scale of trials of all phases in the group of seniors with appropriate assessment of toxicity. This will allow a proper stratification and obtaining representative groups for statistical analysis and credible trial results. Another priority is the design of trials dedicated exclusively to the elderly.

Entities:  

Keywords:  Cancer; Elderly in clinical trials; Senior adults

Year:  2012        PMID: 24381741      PMCID: PMC3863221          DOI: 10.1016/j.rpor.2012.08.006

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  24 in total

Review 1.  Individualized chemotherapy for elderly patients with nonsmall cell lung cancer.

Authors:  Cesare Gridelli; Paolo Maione; Emiddio Barletta
Journal:  Curr Opin Oncol       Date:  2002-03       Impact factor: 3.645

Review 2.  Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG).

Authors:  Martine Extermann; Matti Aapro; Roberto Bernabei; Harvey Jay Cohen; Jean-Pierre Droz; Stuart Lichtman; Vincent Mor; Silvio Monfardini; Lazzaro Repetto; Liv Sørbye; Eva Topinkova
Journal:  Crit Rev Oncol Hematol       Date:  2005-09       Impact factor: 6.312

3.  Entry and evaluation of elderly patients in European Organization for Research and Treatment of Cancer (EORTC) new-drug-development studies.

Authors:  S Monfardini; R Sorio; G H Boes; S Kaye; D Serraino
Journal:  Cancer       Date:  1995-07-15       Impact factor: 6.860

Review 4.  Never too old? Age should not be a barrier to enrollment in cancer clinical trials.

Authors:  Matti S Aapro; Claus-Henning Köhne; Harvey Jay Cohen; Martine Extermann
Journal:  Oncologist       Date:  2005-03

5.  A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients.

Authors:  D J Sargent; R M Goldberg; S D Jacobson; J S Macdonald; R Labianca; D G Haller; L E Shepherd; J F Seitz; G Francini
Journal:  N Engl J Med       Date:  2001-10-11       Impact factor: 91.245

6.  EORTC elderly task force position paper: approach to the older cancer patient.

Authors:  A G Pallis; C Fortpied; U Wedding; M C Van Nes; B Penninckx; A Ring; D Lacombe; S Monfardini; P Scalliet; H Wildiers
Journal:  Eur J Cancer       Date:  2010-03-12       Impact factor: 9.162

Review 7.  Cancer epidemiology in the elderly.

Authors:  S Franceschi; C La Vecchia
Journal:  Crit Rev Oncol Hematol       Date:  2001-09       Impact factor: 6.312

Review 8.  EORTC Elderly Task Force and Lung Cancer Group and International Society for Geriatric Oncology (SIOG) experts' opinion for the treatment of non-small-cell lung cancer in an elderly population.

Authors:  A G Pallis; C Gridelli; J P van Meerbeeck; L Greillier; U Wedding; D Lacombe; J Welch; C P Belani; M Aapro
Journal:  Ann Oncol       Date:  2009-08-28       Impact factor: 32.976

9.  Barriers to clinical trial participation by older women with breast cancer.

Authors:  M Margaret Kemeny; Bercedis L Peterson; Alice B Kornblith; Hyman B Muss; Judith Wheeler; Ellis Levine; Nancy Bartlett; Gini Fleming; Harvey J Cohen
Journal:  J Clin Oncol       Date:  2003-06-15       Impact factor: 44.544

10.  Clinical pharmacology of chemotherapy agents in older people with cancer.

Authors:  Xiaoye He; Stephen J Clarke; Andrew J McLachlan
Journal:  Curr Gerontol Geriatr Res       Date:  2011-08-10
View more
  6 in total

1.  Cancer in the elderly.

Authors:  Jiří Petera; Ladislav Dušek
Journal:  Rep Pract Oncol Radiother       Date:  2012-12-23

Review 2.  Directed differentiation of induced pluripotent stem cells into chondrogenic lineages for articular cartilage treatment.

Authors:  Michał Lach; Tomasz Trzeciak; Magdalena Richter; Jarosław Pawlicz; Wiktoria M Suchorska
Journal:  J Tissue Eng       Date:  2014-09-30       Impact factor: 7.813

3.  Older-Patient-Specific Cancer Trials: A Pooled Analysis of 2,277 Patients (A151715).

Authors:  Dyda Dao; Tyler Zemla; Aminah Jatoi; Rachel A Freedman; Arti Hurria; Hyman Muss; Harvey Jay Cohen; Lawrence N Shulman; Marc Citron; Daniel Budman; Ryan McMurray; Ann Partridge; Lisa Carey; Mina S Sedrak; Jacqueline M Lafky; Jennifer G Le-Rademacher
Journal:  Oncologist       Date:  2019-04-11

4.  Effect of age on the effectiveness of the first-line standard of care treatment in patients with metastatic colorectal cancer: systematic review of observational studies.

Authors:  Mohammed Dagher; Meritxell Sabidó; York Zöllner
Journal:  J Cancer Res Clin Oncol       Date:  2019-06-14       Impact factor: 4.553

5.  Aging and immunotherapies: New horizons for the golden ages.

Authors:  Jamie A G Hamilton; Curtis J Henry
Journal:  Aging Cancer       Date:  2020-09-30

6.  Barriers to clinical trial enrollment of older adults with cancer: A qualitative study of the perceptions of community and academic oncologists.

Authors:  Mina S Sedrak; Supriya G Mohile; Virginia Sun; Can-Lan Sun; Bihong T Chen; Daneng Li; Andrew R Wong; Kevin George; Simran Padam; Jennifer Liu; Vani Katheria; William Dale
Journal:  J Geriatr Oncol       Date:  2019-07-31       Impact factor: 3.599

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.